• English
    • Tiếng Việt
  • English 
    • English
    • Tiếng Việt
  • Login
View Item 
  •   VinSpace Home
  • The College of Health Sciences
  • Nguyen Thanh Liem, MD, PhD
  • View Item
  •   VinSpace Home
  • The College of Health Sciences
  • Nguyen Thanh Liem, MD, PhD
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-N-Methyl-d-Aspartate Receptor Encephalitis: First Case Report

Thumbnail
View/Open
Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-N-Methyl-d-Aspartate Receptor Encephalitis_ First Case Report.pdf (3.770Mb)
Date
2022-06-15
Author
Nguyen Thanh, Liem
Hoang, Van T.
Le Thu, Huong
Nguyen, Phuong Anh Thi
Hoang, Duc M.
Ngo, Doan Van
Cao Vu, Hung
Nguyen Thi Bich, Van
Heke, Michael
Metadata
Show full item record
Abstract
Background: Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis results from altered immune responses and can lead to severe neurological sequelae. This study presents the first case of a patient with significant neurologic impairment following NMDA receptor encephalitis, treated with allogeneic umbilical cord-derived mesenchymal stem/stromal cells (UC-MSCs). Case Presentation: A 5-year-old girl diagnosed with NMDA receptor encephalitis underwent treatment with immunosuppressive medications and intravenous immunoglobulin (IVIG). Despite intensive therapy, her condition deteriorated, leading to the consideration of allogenic UC-MSC therapy. The patient received three intrathecal infusions of xeno- and serum-free cultured UC-MSCs at a dosage of 10^6 cells/kg. Assessment and Results: The patient's condition was evaluated using the German Coma Recovery Scale (CRS), Gross Motor Function Classification System (GMFCS), Gross Motor Function Measure–88 (GMFM-88), Manual Ability Classification System (MACS), Modified Ashworth Scale, and Denver II test at baseline and after each UC-MSC administration. Initially, she was in a permanent vegetative state with diffuse cerebral atrophy. Following the three UC-MSC infusions, there was progressive improvement in cognition and motor functions. At the last follow-up, the patient regained the ability to walk, write, and count, with complete recovery of urinary and bowel control. Brain magnetic resonance imaging (MRI) showed a reduction in cerebral atrophy. Conclusion: The outcomes of this case suggest that UC-MSC therapy may be a promising treatment for autoimmune encephalitis and its associated neurological consequences.
URI
https://vinspace.edu.vn/handle/VIN/417
Collections
  • Nguyen Thanh Liem, MD, PhD [24]

Contact Us | Send Feedback
 

 

Browse

All of VinSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Contact Us | Send Feedback